Hyep Ivan's Form 4 filing
Bicara Therapeutics Inc. (BCAX) · filed Mar 5, 2026
- Accession no.
- 0001628280-26-015421
- Filed
- Mar 5, 2026
- Trade date
- Mar 3-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $301.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hyep IvanCIK 0002034668 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | MOption exerciseAcquired | +7,318 | $3.79 | +$27,735.22 | 152,673 | Direct | |
| Mar 3, 2026 | Common Stock | MOption exerciseAcquired | +6,237 | $3.79 | +$23,638.23 | 158,910 | Direct | |
| Mar 3, 2026 | Common Stock | SSaleDisposed | −13,555 | $18.22 | −$246,972.1 | 145,355 | Direct | |
| Mar 4, 2026 | Common Stock | MOption exerciseAcquired | +2,963 | $3.79 | +$11,229.77 | 148,318 | Direct | |
| Mar 4, 2026 | Common Stock | SSaleDisposed | −2,963 | $18.25 | −$54,074.75 | 145,355 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | MOption exerciseDisposed | −7,318 | $0.00 | $0 | 58,144 | Direct | |
| Mar 3, 2026 | Common Stock | MOption exerciseDisposed | −6,237 | $0.00 | $0 | 82,747 | Direct | |
| Mar 4, 2026 | Common Stock | MOption exerciseDisposed | −2,963 | $0.00 | $0 | 79,784 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.